A new study has suggested that women could reduce their chance of recurring breast cancer by taking aspirin regularly.
Published in the Journal of Clinical Oncology, the research found that taking small doses of the drug several days a week could lower the risk of death from breast cancer as well as decreasing the chances of their being a recurrence of the disease.
Senior author Dr Michelle Homes of Brigham and Women's Hospital and Harvard Medical School, told Reuters: "This is the first study to find that aspirin can significantly reduce the risk of cancer spread and death for women who have been treated for early stage breast cancer."
The researcher also stressed that it was important for women to wait to see if these findings were replicated in clinical trials before beginning to take aspirin as a treatment for breast cancer.
She added that the new way of thinking about cancer was to view it as an inflammatory disease, hence the reason why aspirin, an anti-inflammatory, could help manage the illness.